These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1933695)

  • 1. Treatment of Alzheimer's disease: hopes and reality.
    Gauthier S; Gauthier L; Bouchard R; Quirion R; Sultan S
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):439-41. PubMed ID: 1933695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic approaches to the treatment of Alzheimer's disease.
    Hollander E; Mohs RC; Davis KL
    Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861
    [No Abstract]   [Full Text] [Related]  

  • 3. No response to high-dose muscarinic agonist therapy in Alzheimer's disease.
    Mouradian MM; Mohr E; Williams JA; Chase TN
    Neurology; 1988 Apr; 38(4):606-8. PubMed ID: 3281057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature.
    Jorm AF
    Aust N Z J Psychiatry; 1986 Jun; 20(2):237-40. PubMed ID: 3464268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholinergic agents in the treatment of Alzheimer's disease].
    Zemishlany Z; Davidson M; Davis KL
    Harefuah; 1987 Dec; 113(12):401-4. PubMed ID: 3330722
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic drugs in Alzheimer's disease.
    Davis KL; Mohs RC
    N Engl J Med; 1986 Nov; 315(20):1286-7. PubMed ID: 3773941
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT).
    Wettstein A; Spiegel R
    Psychopharmacology (Berl); 1984; 84(4):572-3. PubMed ID: 6441959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic treatments for Alzheimer's disease.
    Roberts F; Lazareno S
    Biochem Soc Trans; 1989 Feb; 17(1):76-9. PubMed ID: 2653922
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Alzheimer's disease with cholinergic drugs.
    Kumar V; Calache M
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
    Davidson M; Stern RG
    Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term tacrine treatment in Alzheimer's disease.
    Farré M; Roset PN
    Lancet; 1996 Oct; 348(9035):1181-2. PubMed ID: 8888211
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of cholinergic preparations in Alzheimer's disease].
    Bradley RJ; Edge MT; Freeman AM
    Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical drug trials in Alzheimer's disease.
    Crook T
    Ann N Y Acad Sci; 1985; 444():428-36. PubMed ID: 3893271
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.
    Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN
    Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to rational drug development in Alzheimer's disease.
    Iversen LL; Iversen SD; Freedman SB; Dawson G; Rupniak N; Hargreaves RJ; Showell GA; Street LJ; Baker R
    Drug Des Discov; 1993; 9(3-4):251-9. PubMed ID: 8400006
    [No Abstract]   [Full Text] [Related]  

  • 16. Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.
    Byrne EJ; Arie T
    BMJ; 1990 Apr; 300(6732):1132-3; discussion 1131. PubMed ID: 2160850
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A; Rüster P; Romero B; Zimmer R
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract]   [Full Text] [Related]  

  • 18. Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease.
    Davis R; Raby C; Callahan MJ; Lipinski W; Schwarz R; Dudley DT; Lauffer D; Reece P; Jaen J; Tecle H
    Prog Brain Res; 1993; 98():439-45. PubMed ID: 8248534
    [No Abstract]   [Full Text] [Related]  

  • 19. Muscarinic agonists for senile dementia: past experience and future trends.
    Gray JA; Enz A; Spiegel R
    Trends Pharmacol Sci; 1989 Dec; Suppl():85-8. PubMed ID: 2694530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study.
    Agnoli A; Martucci N; Manna V; Conti L; Fioravanti M
    Clin Neuropharmacol; 1983; 6(4):311-23. PubMed ID: 6661730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.